Skip to content

Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System

Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07181876
Acronym
RAS-ACCESS
Enrollment
140
Registered
2025-09-18
Start date
2025-11-26
Completion date
2029-12-01
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia Repair

Brief summary

The purpose of this post-market, observational study is to collect data under anticipated conditions of use that demonstrates that DEXTER performs as intended in the intended patient population, including a variety of representative disease etiologies and demographic groups.

Interventions

DEVICEinguinal hernia repair

Robotic-assisted inguinal hernia repair with the DEXTER robotic surgery system

Sponsors

Distalmotion SA
Lead SponsorINDUSTRY
Veranex, Inc.
CollaboratorUNKNOWN

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is ≥ 22 years of age at time of enrollment/consent * Subject is indicated for and planned to undergo robot-assisted and laparoscopic surgery for unilateral or bilateral inguinal hernia repair * Subject is able and willing to comply with the protocol requirements, has been informed of the nature of the study, and has signed the IRB-approved informed consent form

Exclusion criteria

* Subject with any relative and absolute contraindications for the use of conventional endoscopes and endoscopic surgical instruments and/or general non-procedure specific contraindications to endoscopic surgery including bleeding diathesis and pregnancy * Subject is participating in another clinical investigation at the time of enrollment or planned participation at any time during this clinical study * Subject has a known or suspected medical condition that, in the opinion of the Investigator, may put the subject at risk for participation in this clinical study

Design outcomes

Primary

MeasureTime frameDescription
Primary safety outcomeup to 30 days after surgeryOccurrence of Clavien-Dindo grades III-V adverse events
Primary efficacy outcomeIntraoperativeSuccessful completion of the DEXTER-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach

Countries

United States

Contacts

CONTACTPascal Lehmann
pascal.lehmann@distalmotion.com+41215105890

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026